Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Jun 30, 2020
Date Accepted: Sep 30, 2020

The final, peer-reviewed published version of this preprint can be found here:

Impact of Remote Titration Combined With Telemonitoring on the Optimization of Guideline-Directed Medical Therapy for Patients With Heart Failure: Internal Pilot of a Randomized Controlled Trial

Artanian V, Ross HJ, Rac VE, O'Sullivan M, Brahmbhatt DH, Seto E

Impact of Remote Titration Combined With Telemonitoring on the Optimization of Guideline-Directed Medical Therapy for Patients With Heart Failure: Internal Pilot of a Randomized Controlled Trial

JMIR Cardio 2020;4(1):e21962

DOI: 10.2196/21962

PMID: 33141094

PMCID: 7671843

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Impact of Remote Titration Combined with Telemonitoring on the Optimization of Guideline Directed Medical Therapy for Patients with Heart Failure: Internal Pilot of a Randomized Controlled Trial

  • Veronica Artanian; 
  • Heather J. Ross; 
  • Valeria E. Rac; 
  • Mary O'Sullivan; 
  • Darshan H. Brahmbhatt; 
  • Emily Seto

ABSTRACT

Background:

To improve health outcomes in heart failure patients, guideline directed medical therapy (GDMT) should be optimized to target doses. However, GDMT remains underutilized, with less than 25% of patients receiving target doses in clinical practice. Telemonitoring could provide reliable and real-time physiological data for clinical decision support to facilitate remote GDMT titration.

Objective:

This paper presents findings from an internal pilot study regarding the effectiveness of remote titration facilitated by telemonitoring.

Methods:

A 2-arm randomized controlled pilot trial comparing remote titration vs. standard heart function clinic care was conducted. Patients were randomized to undergo remote medication titration facilitated by data from a smartphone-based telemonitoring system, or standard titration performed during clinic visits.

Results:

42 patients with new onset (10 patients [23.8%]) and existing (32 patients [76.2%]) heart failure, mean age of 55.29 years (SD 11.28 years), were randomized between January and June 2019. Within 6 months of enrolment, 86% of patients in the intervention group achieved optimal doses vs. 48% of patients in the control group. The median time to dose optimization was 11.0 weeks for the intervention group vs. 18.8 weeks for the control group. The number of in-person visits in the intervention group was 54.5% lower than in the control group.

Conclusions:

The results of this pilot study suggest that remote titration facilitated by telemonitoring has the potential to increase the proportion of patients who achieve optimal GDMT doses, decrease time to dose optimization, and reduce the number of clinic visits. Remote titration may facilitate optimal and efficient titration of heart failure patients, while reducing the burden for patients to attend in-person clinic visits. Clinical Trial: ClinicalTrials.gov NCT04205513; https://clinicaltrials.gov/ct2/show/NCT04205513


 Citation

Please cite as:

Artanian V, Ross HJ, Rac VE, O'Sullivan M, Brahmbhatt DH, Seto E

Impact of Remote Titration Combined With Telemonitoring on the Optimization of Guideline-Directed Medical Therapy for Patients With Heart Failure: Internal Pilot of a Randomized Controlled Trial

JMIR Cardio 2020;4(1):e21962

DOI: 10.2196/21962

PMID: 33141094

PMCID: 7671843

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.